Machine learning discriminates P2X7-mediated intracellular calcium sparks in human-induced pluripotent stem cell-derived neural stem cells.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
04 08 2023
Historique:
received: 31 01 2023
accepted: 31 07 2023
medline: 7 8 2023
pubmed: 5 8 2023
entrez: 4 8 2023
Statut: epublish

Résumé

Adenosine triphosphate (ATP) is an extracellular signaling molecule that mainly affects the pathophysiological situation in the body and can be sensed by purinergic receptors, including ionotropic P2X7. Neuronal stem cells (NSCs) remain in adult neuronal tissues and can contribute to physiological processes via activation by evoked pathophysiological situations. In this study, we revealed that human-induced pluripotent stem cell-derived NSCs (iNSCs) have ATP-sensing ability primarily via the purinergic and ionotropic receptor P2X7. Next, to develop a machine learning (ML)-based screening system for food-derived neuronal effective substances and their effective doses, we collected ATP-triggered calcium responses of iNSCs pretreated with several substances and doses. Finally, we discovered that ML was performed using composite images, each containing nine waveform images, to achieve a better ML model (MLM) with higher precision. Our MLM can correctly sort subtle unidentified changes in waveforms produced by pretreated iNSCs with each substance and/or dose into the positive group, with common mRNA expression changes belonging to the gene ontology signatures.

Identifiants

pubmed: 37542080
doi: 10.1038/s41598-023-39846-4
pii: 10.1038/s41598-023-39846-4
pmc: PMC10403609
doi:

Substances chimiques

Calcium SY7Q814VUP
Adenosine Triphosphate 8L70Q75FXE
Receptors, Purinergic P2X7 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12673

Informations de copyright

© 2023. Springer Nature Limited.

Références

Eur J Med Res. 2022 Dec 14;27(1):289
pubmed: 36517841
Sci Rep. 2022 Dec 5;12(1):20963
pubmed: 36471089
J Neurotrauma. 2013 Nov 15;30(22):1872-80
pubmed: 21275797
Purinergic Signal. 2023 Mar;19(1):145-153
pubmed: 35235139
Case Rep Emerg Med. 2015;2015:213874
pubmed: 25861489
J Tissue Eng Regen Med. 2022 Aug;16(8):732-743
pubmed: 35621199
Front Bioeng Biotechnol. 2022 Nov 29;10:1074990
pubmed: 36524054
Neurotoxicol Teratol. 1990 Jul-Aug;12(4):319-26
pubmed: 2118230
Purinergic Signal. 2022 Mar;18(1):135-154
pubmed: 34964926
Asia Pac J Clin Nutr. 2008;17 Suppl 1:167-8
pubmed: 18296328
STAR Protoc. 2022 Aug 06;3(3):101567
pubmed: 35990743
Purinergic Signal. 2020 Sep;16(3):327-336
pubmed: 32583309
Cell Commun Signal. 2013 Feb 17;11(1):12
pubmed: 23414261
J Neurotrauma. 2021 Mar;38(5):655-664
pubmed: 32935624
Mol Pharmacol. 2011 Aug;80(2):247-57
pubmed: 21536754
PLoS Comput Biol. 2017 Jun 7;13(6):e1005526
pubmed: 28591182
Br J Pharmacol. 2013 Oct;170(3):624-40
pubmed: 23889535
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015 Dec;159(4):666-76
pubmed: 25732977
Folia Neuropathol. 2016;54(4):360-368
pubmed: 28139817
N Engl J Med. 2020 Jul 23;383(4):369-378
pubmed: 32706535
JAMA. 1992 Dec 9;268(22):3213-8
pubmed: 1433761
Med Sci Monit. 2019 Aug 24;25:6359-6366
pubmed: 31444877
Front Cell Neurosci. 2014 Sep 01;8:260
pubmed: 25225473
Lancet. 2001 Nov 10;358(9293):1602-7
pubmed: 11716887
J Neurosci Res. 2003 May 1;72(3):352-62
pubmed: 12692902
Front Cell Dev Biol. 2020 Nov 24;8:586555
pubmed: 33330466
Front Mol Neurosci. 2022 Jan 12;14:793769
pubmed: 35095416
Mol Psychiatry. 2022 Nov 21;:
pubmed: 36414713
Science. 2022 Sep 2;377(6610):eabp9444
pubmed: 36048929
J Nutr. 2012 Dec;142(12):2091-6
pubmed: 23096008
Parkinsonism Relat Disord. 2020 Jun;75:105-109
pubmed: 32534431
Neural Regen Res. 2019 Oct;14(10):1684-1694
pubmed: 31169175
Nat Med. 2019 Apr;25(4):554-560
pubmed: 30911133

Auteurs

Yuki Hanafusa (Y)

Innovative Regenerative Medicine, Graduate School of Medicine, Kansai Medical University, Osaka, Japan.
Group Quality Assurance Division, Safety Science Institute, Suntory Holdings Ltd., Tokyo, Japan.

Akira Shiraishi (A)

Division of Integrative Biomolecular Function, Bioorganic Research Institute, Suntory Foundation for Life Sciences, Kyoto, Japan.

Fumiyuki Hattori (F)

Innovative Regenerative Medicine, Graduate School of Medicine, Kansai Medical University, Osaka, Japan. hattorif@hirakata.kmu.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH